NCT03846739View on ClinicalTrials.gov

Dose-dependent Effects of Oxytocin on the Amygdala and Reward System

PHASE1CompletedINTERVENTIONAL
Enrollment

92

Participants

Timeline

Start Date

April 3, 2017

Primary Completion Date

December 31, 2018

Study Completion Date

December 31, 2018

Conditions
Healthy
Interventions
DRUG

Oxytocin nasal spray

Intranasal administration, 6, 12, or 24 international units (IU) oxytocin.

DRUG

Placebo

The placebo nasal sprays contain identical ingredients except for the peptide itself.

Trial Locations (1)

53105

Department of Psychiatry, University of Bonn, Bonn

All Listed Sponsors
lead

University Hospital, Bonn

OTHER

NCT03846739 - Dose-dependent Effects of Oxytocin on the Amygdala and Reward System | Biotech Hunter | Biotech Hunter